Latest filing published 10 Jun 2026 for Horizon Technology Finance Corp.
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Filings by Michael Balkin span 2 companies, the busiest being Horizon Technology Finance Corp and P3 Health Partners Inc. We count 9 filings; the first trade dates from 12 February 2021 and the latest from 9 June 2026.
The open-market record is one-sided, with 6 purchases worth €719k and not one sale. The totals do not cover 1 filing with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 2 share grants. So far in 2026, the count stands at 1 purchase and no sales.
The median purchase comes to €97k. Of 5 purchases, 3 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
On 10 June 2026 came the latest disclosure, a share grant in Horizon Technology Finance Corp. The most recent open-market purchase was published on 10 June 2026, 136 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations